32 results on '"Sánchez-Tilló E"'
Search Results
2. Accelerated DNA replication in E2F1- and E2F2-deficient macrophages leads to induction of the DNA damage response and p21CIP1-dependent senescence
- Author
-
Iglesias-Ara, A, Zenarruzabeitia, O, Fernandez-Rueda, J, Sánchez-Tilló, E, Field, S J, Celada, A, and Zubiaga, A M
- Published
- 2010
- Full Text
- View/download PDF
3. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
- Author
-
Sánchez-Tilló, E, Lázaro, A, Torrent, R, Cuatrecasas, M, Vaquero, E C, Castells, A, Engel, P, and Postigo, A
- Published
- 2010
- Full Text
- View/download PDF
4. ZEB1 induces the Wnt antagonist DKK1 to jointly determine poorer survival in colorectal carcinomas
- Author
-
De Barrios, O., primary, Győrffy, B., additional, Fernández-Aceñero, M.J., additional, Sánchez-Tilló, E., additional, Casal, J.I., additional, Darling, D.S., additional, Castells, A., additional, and Postigo, A., additional
- Published
- 2016
- Full Text
- View/download PDF
5. 104: ZEB1 modulates expression of CDX1 and CDX2 caudal homeobox genes in colorectal carcinoma cell lines
- Author
-
De Barrios, O., primary, Orozco, C.A., additional, Sánchez-Tilló, E., additional, Fanlo, L., additional, Castells, A., additional, and Postigo, A., additional
- Published
- 2014
- Full Text
- View/download PDF
6. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma
- Author
-
Sánchez-Tilló, E, primary, Fanlo, L, additional, Siles, L, additional, Montes-Moreno, S, additional, Moros, A, additional, Chiva-Blanch, G, additional, Estruch, R, additional, Martinez, A, additional, Colomer, D, additional, Győrffy, B, additional, Roué, G, additional, and Postigo, A, additional
- Published
- 2013
- Full Text
- View/download PDF
7. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.
- Author
-
Sánchez-Tilló, E, Fanlo, L, Siles, L, Montes-Moreno, S, Moros, A, Chiva-Blanch, G, Estruch, R, Martinez, A, Colomer, D, Győrffy, B, Roué, G, and Postigo, A
- Subjects
- *
LYMPHOMA treatment , *TUMOR growth , *CANCER chemotherapy , *SALINOMYCIN , *XENOGRAFTS , *METASTASIS - Abstract
Mantle cell lymphoma (MCL) is a B-cell malignancy characterized by a poor response to treatment and prognosis. Constitutive activation of different signaling pathways in subsets of MCLs, through genetic and/or nongenetic alterations, endows tumor cells with enhanced proliferation and reduced apoptosis. The canonical Wnt pathway (β-catenin/TCF-LEF), implicated in the pathogenesis of numerous cancers, is constitutively active in half of MCLs. Here, we show that ZEB1, a transcription factor better known for promoting metastasis in carcinomas, is expressed in primary MCLs with active Wnt signaling. ZEB1 expression in MCL cells depends on Wnt, being downregulated by β-catenin knockdown or blocking of Wnt signaling by salinomycin. Knockdown of ZEB1 reduces in vitro cell viability and proliferation in MCL cells, and, importantly, tumor growth in mouse xenograft models. ZEB1 activates proliferation-associated (HMGB2, UHRF1, CENPF, MYC, MKI67, and CCND1) and anti-apoptotic (MCL1, BCL2, and BIRC5) genes and inhibits pro-apoptotic ones (TP53, BBC3, PMAIP1, and BAX). We show that ZEB1 expression in MCL cells determines differential resistance to chemotherapy drugs and regulates transporters involved in drug influx/efflux. Downregulation of ZEB1 by salinomycin increases the sensitivity of MCL cells to the cytotoxic effect of doxorubicin, cytarabine and gemcitabine. Lastly, salinomycin and doxorubicin display a synergistic effect in established and primary MCL cells. These results identify ZEB1 in MCL where it promotes cell proliferation, enhanced tumor growth and a differential response to chemotherapy drugs. ZEB1 could thus potentially become a predictive biomarker and therapeutic target in this lymphoma. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
8. Accelerated DNA replication in E2F1- and E2F2-deficient macrophages leads to induction of the DNA damage response and p21CIP1-dependent senescence.
- Author
-
Iglesias-Ara, A, Zenarruzabeitia, O, Fernandez-Rueda, J, Sánchez-Tilló, E, Field, S J, Celada, A, and Zubiaga, A M
- Subjects
DNA replication ,MACROPHAGES ,DNA damage ,CELL differentiation ,LABORATORY mice ,CELL cycle ,CELL proliferation ,CELLULAR aging ,CELL division - Abstract
E2F1-3 proteins appear to have distinct roles in progenitor cells and in differentiating cells undergoing cell cycle exit. However, the function of these proteins in paradigms of terminal differentiation that involve continued cell division has not been examined. Using compound E2F1/E2F2-deficient mice, we have examined the effects of E2F1 and E2F2 loss on the differentiation and simultaneous proliferation of bone-marrow-derived cells toward the macrophage lineage. We show that E2F1/E2F2 deficiency results in accelerated DNA replication and cellular division during the initial cell division cycles of bone-marrow-derived cells, arguing that E2F1/E2F2 are required to restrain proliferation of pro-monocyte progenitors during their differentiation into macrophages, without promoting their cell cycle exit. Accelerated proliferation is accompanied by early expression of DNA replication and cell cycle regulators. Remarkably, rapid proliferation of E2F1/E2F2 compound mutant cultures is temporally followed by induction of a DNA damage response and the implementation of a p21
CIP1 -dependent senescence. We further show that differentiating E2F1/E2F2-knockout macrophages do not trigger a DNA damage response pathway in the absence of DNA replication. These findings underscore the relevance of E2F1 and E2F2 as suppressors of hematopoietic progenitor expansion. Our data indicate that their absence in differentiating macrophages initiates a senescence program that results from enforcement of a DNA damage response triggered by DNA hyper-replication. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
9. Erratum: Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages (The Journal of Biological Chemistry (2003) 278 (46307-46320))
- Author
-
Vicente, R., Escalada, A., Coma, M., Fuster, G., Sánchez-Tilló, E., López-Iglesias, C., Soler, C., Solsona, C., Antonio Celada, and Felipe, A.
10. 226 - ZEB1 induces the Wnt antagonist DKK1 to jointly determine poorer survival in colorectal carcinomas.
- Author
-
De Barrios, O., Győrffy, B., Fernández-Aceñero, M.J., Sánchez-Tilló, E., Casal, J.I., Darling, D.S., Castells, A., and Postigo, A.
- Published
- 2016
- Full Text
- View/download PDF
11. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas.
- Author
-
Sánchez-Tilló E, Pedrosa L, Vila I, Chen Y, Győrffy B, Sánchez-Moral L, Siles L, Lozano JJ, Esteve-Codina A, Darling DS, Cuatrecasas M, Castells A, Maurel J, and Postigo A
- Subjects
- Animals, Humans, Mice, Proto-Oncogene Proteins p21(ras) genetics, Proto-Oncogene Proteins p21(ras) metabolism, Signal Transduction, Carcinoma, Colorectal Neoplasms pathology, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins B-raf metabolism, Zinc Finger E-box-Binding Homeobox 1 genetics, Zinc Finger E-box-Binding Homeobox 1 metabolism
- Abstract
Despite being in the same pathway, mutations of KRAS and BRAF in colorectal carcinomas (CRCs) determine distinct progression courses. ZEB1 induces an epithelial-to-mesenchymal transition (EMT) and is associated with worse progression in most carcinomas. Using samples from patients with CRC, mouse models of KrasG12D and BrafV600E CRC, and a Zeb1-deficient mouse, we show that ZEB1 had opposite functions in KRAS- and BRAF-mutant CRCs. In KrasG12D CRCs, ZEB1 was correlated with a worse prognosis and a higher number of larger and undifferentiated (mesenchymal or EMT-like) tumors. Surprisingly, in BrafV600E CRC, ZEB1 was associated with better prognosis; fewer, smaller, and more differentiated (reduced EMT) primary tumors; and fewer metastases. ZEB1 was positively correlated in KRAS-mutant CRC cells and negatively in BRAF-mutant CRC cells with gene signatures for EMT, cell proliferation and survival, and ERK signaling. On a mechanistic level, ZEB1 knockdown in KRAS-mutant CRC cells increased apoptosis and reduced clonogenicity and anchorage-independent growth; the reverse occurred in BRAFV600E CRC cells. ZEB1 is associated with better prognosis and reduced EMT signature in patients harboring BRAF CRCs. These data suggest that ZEB1 can function as a tumor suppressor in BRAF-mutant CRCs, highlighting the importance of considering the KRAS/BRAF mutational background of CRCs in therapeutic strategies targeting ZEB1/EMT.
- Published
- 2023
- Full Text
- View/download PDF
12. Induction of CIITA by IFN-γ in macrophages involves STAT1 activation by JAK and JNK.
- Author
-
Tur J, Farrera C, Sánchez-Tilló E, Vico T, Guerrero-Gonzalez P, Fernandez-Elorduy A, Lloberas J, and Celada A
- Subjects
- Animals, Cell Line, Cyclosporine pharmacology, Lactones pharmacology, Mice, Inbred BALB C, Nuclear Proteins genetics, Spiro Compounds pharmacology, Trans-Activators genetics, Mice, Interferon-gamma immunology, JNK Mitogen-Activated Protein Kinases immunology, Janus Kinases immunology, Nuclear Proteins immunology, STAT1 Transcription Factor immunology, Trans-Activators immunology
- Abstract
The induction of major histocompatibility complex (MHC) class II proteins by interferon gamma (IFN-γ) in macrophages play an important role during immune responses. Here we explore the signaling pathways involved in the induction by IFN-γ of the MHC II transactivator (CIIta) required for MHC II transcriptional activation. Cyclophilin A (CypA) is required for IFN-γ-dependent induction of MHC II in macrophages, but not when it is mediated by GM-CSF. The effect of CypA appears to be specific because it does not affect the expression of other molecules or genes triggered by IFN-γ, such as FcγR, NOS2, Lmp2, and Tap1. We found that CypA inhibition blocked the IFN-γ-induced expression of CIIta at the transcriptional level in two phases. In an early phase, during the first 2 h of IFN-γ treatment, STAT1 is phosphorylated at Tyrosine 701 and Serine 727, residues required for the induction of the transcription factor IRF1. In a later phase, STAT1 phosphorylation and JNK activation are required to trigger CIIta expression. CypA is needed for STAT1 phosphorylation in this last phase and to bind the CIIta promoter. Our findings demonstrate that STAT1 is required in a two-step induction of CIIta, once again highlighting the significance of cross talk between signaling pathways in macrophages., (Copyright © 2021 The Author(s). Published by Elsevier GmbH.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
13. ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1.
- Author
-
de Barrios O, Győrffy B, Fernández-Aceñero MJ, Sánchez-Tilló E, Sánchez-Moral L, Siles L, Esteve-Arenys A, Roué G, Casal JI, Darling DS, Castells A, and Postigo A
- Subjects
- Alcohol Oxidoreductases genetics, Alcohol Oxidoreductases metabolism, Animals, Cell Line, Tumor, Cell Survival genetics, Cellular Senescence genetics, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Gene Expression Regulation, Neoplastic, Heterografts, Histones metabolism, Humans, Intercellular Signaling Peptides and Proteins metabolism, Mice, Mice, Transgenic, Mutation, Proto-Oncogene Proteins c-mdm2 genetics, Proto-Oncogene Proteins c-mdm2 metabolism, Survival Rate, Transcription, Genetic, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Up-Regulation, Wnt Signaling Pathway, Zinc Finger E-box-Binding Homeobox 1 metabolism, Carcinogenesis genetics, Colonic Neoplasms genetics, Colonic Neoplasms metabolism, Histones genetics, Intercellular Signaling Peptides and Proteins genetics, Zinc Finger E-box-Binding Homeobox 1 genetics
- Abstract
Objective: Understand the role of ZEB1 in the tumour initiation and progression beyond inducing an epithelial-to-mesenchymal transition., Design: Expression of the transcription factor ZEB1 associates with a worse prognosis in most cancers, including colorectal carcinomas (CRCs). The study uses survival analysis, in vivo mouse transgenic and xenograft models, gene expression arrays, immunostaining and gene and protein regulation assays., Results: The poorer survival determined by ZEB1 in CRCs depended on simultaneous high levels of the Wnt antagonist DKK1 , whose expression was transcriptionally activated by ZEB1. In cancer cells with mutant TP53 , ZEB1 blocked the formation of senescence-associated heterochromatin foci at the onset of senescence by triggering a new regulatory cascade that involves the subsequent activation of DKK1, mutant p53, Mdm2 and CtBP to ultimately repress macroH2A1 ( H2AFY ). In a transgenic mouse model of colon cancer, partial downregulation of Zeb1 was sufficient to induce H2afy and to trigger in vivo tumour senescence, thus resulting in reduced tumour load and improved survival. The capacity of ZEB1 to induce tumourigenesis in a xenograft mouse model requires the repression of H2AFY by ZEB1. Lastly, the worst survival effect of ZEB1 in patients with CRC ultimately depends on low expression of H2AFY and of senescence-associated genes., Conclusions: The tumourigenic capacity of ZEB1 depends on its inhibition of cancer cell senescence through the activation of a herein identified new molecular pathway. These results set ZEB1 as a potential target in therapeutic strategies aimed at inducing senescence., (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.)
- Published
- 2017
- Full Text
- View/download PDF
14. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.
- Author
-
Liu Y, Sánchez-Tilló E, Lu X, Huang L, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, and Dean DC
- Subjects
- Animals, Cell Line, Tumor, Cell Transformation, Neoplastic genetics, Cell Transformation, Neoplastic pathology, Cellular Senescence genetics, Homeodomain Proteins genetics, Mice, Mice, Inbred BALB C, Mice, Knockout, Mice, Nude, MicroRNAs genetics, Mutation, Neoplasms genetics, Neoplasms pathology, Oncogene Protein p21(ras) genetics, Polycomb Repressive Complex 1 genetics, Proto-Oncogene Proteins genetics, RNA, Neoplasm genetics, Retinoblastoma Protein genetics, Transcription Factors genetics, Zinc Finger E-box-Binding Homeobox 1, Cell Transformation, Neoplastic metabolism, Gene Expression Regulation, Neoplastic, Homeodomain Proteins metabolism, MicroRNAs metabolism, Neoplasms metabolism, Oncogene Protein p21(ras) biosynthesis, Polycomb Repressive Complex 1 biosynthesis, Proto-Oncogene Proteins biosynthesis, RNA, Neoplasm metabolism, Retinoblastoma Protein biosynthesis, Transcription Factors metabolism
- Abstract
Ras mutations are frequent in cancer cells where they drive proliferation and resistance to apoptosis. However in primary cells, mutant Ras instead can cause oncogene-induced senescence, a tumor suppressor function linked to repression of the polycomb factor Bmi1, which normally regulates cell cycle inhibitory cyclin-dependent kinase inhibitors (cdki). It is unclear how Ras causes repression of Bmi1 in primary cells to suppress tumor formation while inducing the gene in cancer cells to drive tumor progression. Ras also induces the EMT transcription factor ZEB1 to trigger tumor invasion and metastasis. Beyond its well-documented role in EMT, ZEB1 is important for maintaining repression of cdki. Indeed, heterozygous mutation of ZEB1 is sufficient for elevated cdki expression, leading to premature senescence of primary cells. A similar phenotype is evident with Bmi1 mutation. We show that activation of Rb1 in response to mutant Ras causes dominant repression of ZEB1 in primary cells, but loss of the Rb1 pathway is a hallmark of cancer cells and in the absence of such Rb1 repression Ras induces ZEB1 in cancer cells. ZEB1 represses miR-200 in the context of a mutual repression loop. Because miR-200 represses Bmi1, induction of ZEB1 leads to induction of Bmi1. Rb1 pathway status then dictates the opposing effects of mutant Ras on the ZEB1-miR-200 loop in primary versus cancer cells. This loop not only triggers EMT, surprisingly we show it acts downstream of Ras to regulate Bmi1 expression and thus the critical decision between oncogene-induced senescence and tumor initiation.
- Published
- 2014
- Full Text
- View/download PDF
15. Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.
- Author
-
Liu Y, Sánchez-Tilló E, Lu X, Huang L, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, and Dean DC
- Subjects
- Animals, Cell Transformation, Neoplastic genetics, Cell Transformation, Neoplastic pathology, Cellular Senescence genetics, Embryo, Mammalian metabolism, Embryo, Mammalian pathology, Fibroblasts metabolism, Fibroblasts pathology, Gene Expression Regulation, Neoplastic genetics, Homeodomain Proteins genetics, Kruppel-Like Transcription Factors genetics, Mice, Mice, Inbred BALB C, Mice, Knockout, Mice, Nude, MicroRNAs biosynthesis, MicroRNAs genetics, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms genetics, Neoplasms pathology, RNA, Neoplasm biosynthesis, RNA, Neoplasm genetics, Retinoblastoma Protein genetics, Zinc Finger E-box-Binding Homeobox 1, ras Proteins genetics, Cell Transformation, Neoplastic metabolism, Homeodomain Proteins metabolism, Kruppel-Like Transcription Factors metabolism, Mutation, Neoplasms metabolism, Retinoblastoma Protein metabolism, ras Proteins metabolism
- Abstract
Rb1 restricts cell cycle progression, and it imposes cell contact inhibition to suppress tumor outgrowth. It also triggers oncogene-induced senescence to block Ras mutation. Loss of the Rb1 pathway, which is a hallmark of cancer cells, then provides a permissive environment for Ras mutation, and Ras is sufficient for invasive tumor formation in Rb1 family mutant mouse embryo fibroblasts (MEFs). These results demonstrate that sequential mutation of the Rb1 and Ras pathways comprises a tumor initiation axis. Both Rb1 and Ras regulate expression of the transcription factor ZEB1, thereby linking tumor initiation to the subsequent invasion and metastasis, which is induced by ZEB1. ZEB1 acts in a negative feedback loop to block expression of miR-200, which is thought to facilitate tumor invasion and metastasis. However, ZEB1 also represses cyclin-dependent kinase (cdk) inhibitors to control the cell cycle; its mutation in MEFs leads to induction of these inhibitors and premature senescence. Here, we provide evidence for two sequential inductions of ZEB1 during Ras transformation of MEFs. Rb1 constitutively represses cdk inhibitors, and induction of ZEB1 when the Rb1 pathway is lost is required to maintain this repression, allowing for the classic immortalization and loss of cell contact inhibition seen when the Rb1 pathway is lost. In vivo, we show that this induction of ZEB1 is required for Ras-initiated tumor formation. ZEB1 is then further induced by Ras, beyond the level seen with Rb1 mutation, and this Ras superinduction is required to reach a threshold of ZEB1 sufficient for repression of miR-200 and tumor invasion.
- Published
- 2013
- Full Text
- View/download PDF
16. ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.
- Author
-
Siles L, Sánchez-Tilló E, Lim JW, Darling DS, Kroll KL, and Postigo A
- Subjects
- Alcohol Oxidoreductases genetics, Alcohol Oxidoreductases metabolism, Animals, Cell Line, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, E-Box Elements, Gene Expression, Homeodomain Proteins metabolism, Kruppel-Like Transcription Factors metabolism, Mice, Mice, Inbred C57BL, Muscle Development genetics, Muscle Fibers, Skeletal metabolism, Muscle, Skeletal cytology, Muscle, Skeletal metabolism, MyoD Protein genetics, MyoD Protein metabolism, Myoblasts metabolism, Repressor Proteins genetics, Repressor Proteins metabolism, Transcription Factors genetics, Transcription Factors metabolism, Transcription, Genetic, Xenopus laevis, Zinc Finger E-box-Binding Homeobox 1, Cell Differentiation genetics, Gene Expression Regulation, Homeodomain Proteins genetics, Kruppel-Like Transcription Factors genetics, Muscle, Skeletal physiology, Transcriptional Activation
- Abstract
Skeletal muscle development is orchestrated by the myogenic regulatory factor MyoD, whose activity is blocked in myoblasts by proteins preventing its nuclear translocation and/or binding to G/C-centered E-boxes in target genes. Recent evidence indicates that muscle gene expression is also regulated at the cis level by differential affinity for DNA between MyoD and other E-box binding proteins during myogenesis. MyoD binds to G/C-centered E-boxes, enriched in muscle differentiation genes, in myotubes but not in myoblasts. Here, we used cell-based and in vivo Drosophila, Xenopus laevis, and mouse models to show that ZEB1, a G/C-centered E-box binding transcriptional repressor, imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression. We found that, contrary to MyoD, ZEB1 binds to G/C-centered E-boxes in muscle differentiation genes at the myoblast stage but not in myotubes. Its knockdown results in precocious expression of muscle differentiation genes and acceleration of myotube formation. Inhibition of muscle genes by ZEB1 occurs via transcriptional repression and involves recruitment of the CtBP corepressor. Lastly, we show that the pattern of gene expression associated with muscle differentiation is accelerated in ZEB1(-/-) mouse embryos. These results set ZEB1 as an important regulator of the temporal pattern of gene expression controlling muscle differentiation.
- Published
- 2013
- Full Text
- View/download PDF
17. ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1.
- Author
-
Sánchez-Tilló E, de Barrios O, Siles L, Amendola PG, Darling DS, Cuatrecasas M, Castells A, and Postigo A
- Subjects
- Animals, Blotting, Western, Cell Movement, Cells, Cultured, Chromatin Immunoprecipitation, Colorectal Neoplasms genetics, Colorectal Neoplasms metabolism, Embryo, Mammalian cytology, Embryo, Mammalian metabolism, Fibroblasts cytology, Fibroblasts metabolism, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, Neoplasm Invasiveness, Plasminogen Activator Inhibitor 1 genetics, Promoter Regions, Genetic, RNA Stability, RNA, Messenger genetics, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Transcription, Genetic, Urokinase-Type Plasminogen Activator genetics, Wnt Proteins genetics, Wnt Proteins metabolism, Zinc Finger E-box-Binding Homeobox 1, p300-CBP Transcription Factors genetics, p300-CBP Transcription Factors metabolism, Colorectal Neoplasms pathology, Gene Expression Regulation, Neoplastic, Homeodomain Proteins physiology, Kruppel-Like Transcription Factors physiology, Plasminogen Activator Inhibitor 1 metabolism, Urokinase-Type Plasminogen Activator metabolism
- Abstract
Purpose: Carcinoma cells enhance their invasive capacity through dedifferentiation and dissolution of intercellular adhesions. A key activator of this process is the ZEB1 transcription factor, which is induced in invading cancer cells by canonical Wnt signaling (β-catenin/TCF4). Tumor invasiveness also entails proteolytic remodeling of the peritumoral stroma. This study aimed to investigate the potential regulation by ZEB1 of the plasminogen proteolytic system constituted by the urokinase plasminogen activator (uPA), and its inhibitor, plasminogen activator inhibitor-1 (PAI-1)., Experimental Design: Through multiple experimental approaches, colorectal carcinoma (CRC) cell lines and samples from human primary CRC and ZEB1 (-/-) mice were used to examine ZEB1-mediated regulation of uPA and PAI-1 at the protein, mRNA, and transcriptional level., Results: ZEB1 regulates uPA and PAI-1 in opposite directions: induces uPA and inhibits PAI-1. In vivo expression of uPA depends on ZEB1 as it is severely reduced in the developing intestine of ZEB1 null (-/-) mice. Optimal induction of uPA by Wnt signaling requires ZEB1 expression. ZEB1 binds to the uPA promoter and activates its transcription through a mechanism implicating the histone acetyltransferase p300. In contrast, inhibition of PAI-1 by ZEB1 does not involve transcriptional repression but rather downregulation of mRNA stability. ZEB1-mediated tumor cell migration and invasion depend on its induction of uPA. ZEB1 coexpresses with uPA in cancer cells at the invasive front of CRCs., Conclusions: ZEB1 promotes tumor invasiveness not only via induction in cancer cells of a motile dedifferentiated phenotype but also by differential regulation of genes involved in stroma remodeling., (©2013 AACR.)
- Published
- 2013
- Full Text
- View/download PDF
18. Rb1 family mutation is sufficient for sarcoma initiation.
- Author
-
Liu Y, Sánchez-Tilló E, Lu X, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, and Dean DC
- Subjects
- Animals, Anoikis, Cell Proliferation, Cell Transformation, Neoplastic metabolism, Cell Transformation, Neoplastic pathology, Fibroblasts metabolism, Fibroblasts pathology, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Kruppel-Like Transcription Factors genetics, Kruppel-Like Transcription Factors metabolism, Mice, Mice, Nude, Neoplasm Invasiveness, Proto-Oncogene Proteins c-akt genetics, Proto-Oncogene Proteins c-akt metabolism, Retinoblastoma Protein metabolism, Sarcoma, Experimental metabolism, Sarcoma, Experimental pathology, Signal Transduction, Skin Neoplasms metabolism, Skin Neoplasms pathology, Zinc Finger E-box-Binding Homeobox 1, ras Proteins genetics, ras Proteins metabolism, Cell Transformation, Neoplastic genetics, Gene Expression Regulation, Neoplastic, Mutation, Retinoblastoma Protein genetics, Sarcoma, Experimental genetics, Skin Neoplasms genetics
- Abstract
It is thought that genomic instability precipitated by Rb1 pathway loss rapidly triggers additional cancer gene mutations, accounting for rapid tumour onset following Rb1 mutation. However, recent whole-genome sequencing of retinoblastomas demonstrated little genomic instability, but instead suggested rapid epigenetic activation of cancer genes. These results raise the possibility that loss of the Rb1 pathway, which is a hallmark of cancers, might be sufficient for cancer initiation. Yet, mutation of the Rb1 family or inactivation of the Rb1 pathway in primary cells has proven insufficient for tumour initiation. Here we demonstrate that traditional nude mouse assays impose an artificial anoikis and proliferation barrier that prevents Rb1 family mutant fibroblasts from initiating tumours. By circumventing this barrier, we show that primary fibroblasts with only an Rb1 family mutation efficiently form sarcomas in nude mice, and a Ras-ZEB1-Akt pathway then causes transition of these tumours to an invasive phenotype.
- Published
- 2013
- Full Text
- View/download PDF
19. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.
- Author
-
Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A, and Postigo A
- Subjects
- Animals, Humans, Mice, Neoplasm Invasiveness, Activating Transcription Factors metabolism, Cell Transformation, Neoplastic pathology, Epithelial-Mesenchymal Transition, Neoplasms metabolism, Neoplasms pathology
- Abstract
Cancer is a complex multistep process involving genetic and epigenetic changes that eventually result in the activation of oncogenic pathways and/or inactivation of tumor suppressor signals. During cancer progression, cancer cells acquire a number of hallmarks that promote tumor growth and invasion. A crucial mechanism by which carcinoma cells enhance their invasive capacity is the dissolution of intercellular adhesions and the acquisition of a more motile mesenchymal phenotype as part of an epithelial-to-mesenchymal transition (EMT). Although many transcription factors can trigger it, the full molecular reprogramming occurring during an EMT is mainly orchestrated by three major groups of transcription factors: the ZEB, Snail and Twist families. Upregulated expression of these EMT-activating transcription factors (EMT-ATFs) promotes tumor invasiveness in cell lines and xenograft mice models and has been associated with poor clinical prognosis in human cancers. Evidence accumulated in the last few years indicates that EMT-ATFs also regulate an expanding set of cancer cell capabilities beyond tumor invasion. Thus, EMT-ATFs have been shown to cooperate in oncogenic transformation, regulate cancer cell stemness, override safeguard programs against cancer like apoptosis and senescence, determine resistance to chemotherapy and promote tumor angiogenesis. This article reviews the expanding portfolio of functions played by EMT-ATFs in cancer progression.
- Published
- 2012
- Full Text
- View/download PDF
20. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
- Author
-
Sánchez-Tilló E, de Barrios O, Siles L, Cuatrecasas M, Castells A, and Postigo A
- Subjects
- Animals, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors genetics, Blotting, Western, Cell Line, Chromatin Immunoprecipitation, DNA Primers genetics, Fluorescent Antibody Technique, Gene Knockdown Techniques, Homeodomain Proteins genetics, Humans, Immunohistochemistry, Mice, Mutagenesis, Site-Directed, Promoter Regions, Genetic genetics, RNA, Small Interfering genetics, Real-Time Polymerase Chain Reaction, Signal Transduction physiology, Transcription Factor 4, Transcription Factors genetics, Zinc Finger E-box-Binding Homeobox 1, beta Catenin genetics, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors metabolism, Epithelial-Mesenchymal Transition physiology, Gene Expression Regulation, Neoplastic physiology, Homeodomain Proteins metabolism, Multiprotein Complexes metabolism, Neoplasm Invasiveness physiopathology, Transcription Factors metabolism, beta Catenin metabolism
- Abstract
In most carcinomas, invasion of malignant cells into surrounding tissues involves their molecular reprogramming as part of an epithelial-to-mesenchymal transition (EMT). Mutation of the APC gene in most colorectal carcinomas (CRCs) contributes to the nuclear translocation of the oncoprotein β-catenin that upon binding to T-cell and lymphoid enhancer (TCF-LEF) factors triggers an EMT and a proinvasive gene expression profile. A key inducer of EMT is the ZEB1 transcription factor whose expression promotes tumorigenesis and metastasis in carcinomas. As inhibitor of the epithelial phenotype, ZEB1 is never present in the epithelium of normal colon or the tumor center of CRCs where β-catenin remains membranous. We show here that ZEB1 is expressed by epithelial cells in intestinal tumors from human patients (familial adenomatous polyposis) and mouse models (APC(Min/+)) with germline mutations of APC that result in nuclear accumulation of β-catenin. However, ZEB1 is not expressed in the epithelium of hereditary forms of CRCs that carry wild-type APC and where β-catenin is excluded from the nucleus (Lynch syndrome). We found that β-catenin/TCF4 binds directly to the ZEB1 promoter and activates its transcription. Knockdown of β-catenin and TCF4 in APC-mutated CRC cells inhibited endogenous ZEB1, whereas forced translocation of β-catenin to the nucleus in APC-wild-type CRC cells induced de novo expression of ZEB1. Upregulation of MT1-MMP and LAMC2 by β-catenin/TCF4 has been linked to invasiveness in CRCs, and we show here that both proteins are activated by ZEB1 coexpressing with it in primary colorectal tumors with mutated APC. These results set ZEB1 as an effector of β-catenin/TCF4 signaling in EMT and tumor progression.
- Published
- 2011
- Full Text
- View/download PDF
21. Expanding roles of ZEB factors in tumorigenesis and tumor progression.
- Author
-
Sánchez-Tilló E, Siles L, de Barrios O, Cuatrecasas M, Vaquero EC, Castells A, and Postigo A
- Abstract
The ZEB family of transcription factors regulates key factors during embryonic development and cell differentiation but their role in cancer biology has only more recently begun to be recognized. Early evidence showed that ZEB proteins induce an epithelial-to-mesenchymal transition linking their expression with increased aggressiveness and metastasis in mice models and a wide range of primary human carcinomas. Reports over the last few years have found that ZEB proteins also play critical roles in the maintenance of cancer cell stemness, control of replicative senescence, tumor angiogenesis, overcoming of oncogenic addiction and resistance to chemotherapy. These expanding roles in tumorigenesis and tumor progression set ZEB proteins as potential diagnostic, prognostic and therapeutic targets.
- Published
- 2011
22. ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus.
- Author
-
Papadopoulou V, Postigo A, Sánchez-Tilló E, Porter AC, and Wagner SD
- Subjects
- Alcohol Oxidoreductases genetics, Base Sequence, Cell Line, Cell Line, Tumor, Chromatin Immunoprecipitation, Homeodomain Proteins genetics, Humans, Molecular Sequence Data, Promoter Regions, Genetic genetics, Protein Binding genetics, Proto-Oncogene Proteins c-bcl-6, RNA, Small Interfering, Reverse Transcriptase Polymerase Chain Reaction, Sequence Homology, Amino Acid, Transcription Factors genetics, Transcription Initiation Site, Zinc Finger E-box-Binding Homeobox 1, Alcohol Oxidoreductases metabolism, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Homeodomain Proteins metabolism, Transcription Factors metabolism
- Abstract
BCL6 is essential for normal antibody responses and is highly expressed in germinal centre B-cells. Constitutive expression due to chromosomal translocations or mutations of cis-acting regulatory elements contributes to diffuse large B-cell lymphoma. BCL6 expression is therefore tightly regulated in a lineage- and developmental-stage-specific manner, and disruption of normal controls can contribute to lymphomagenesis. In order to discover potential cis-acting control regions we carried out DNase I-hypersensitive site mapping. Gel-shift assays and chromatin immunoprecipitation of the core region of a hypersensitive site 4.4 kb upstream of BCL6 transcription initiation (HSS-4.4) showed an E-box element-binding ZEB1 (zinc finger E-boxbinding homeobox 1) and the co-repressor CtBP (C-terminal binding protein). As compared with peripheral blood B-cells, ZEB1, a two-handed zinc finger transcriptional repressor, is expressed at relatively low levels in germinal centre cells, whereas BCL6 has the opposite pattern of expression. Transfection of ZEB1 cDNA caused a reduction in BCL6 expression and a mutated ZEB1, incapable of binding CtBP, lacked this effect. siRNA (small interfering RNA)-mediated knockdown of ZEB1 or CtBP produced an increase in BCL6 mRNA. We propose that HSS-4.4 is a distal promoter element binding a repressive complex consisting of ZEB1 and CtBP. CtBP is ubiquitously expressed and the results of the present study suggest that regulation of ZEB1 is required for control of BCL6 expression.
- Published
- 2010
- Full Text
- View/download PDF
23. CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation.
- Author
-
Casals-Casas C, Alvarez E, Serra M, de la Torre C, Farrera C, Sánchez-Tilló E, Caelles C, Lloberas J, and Celada A
- Subjects
- Animals, Binding Sites, Blotting, Western, Bone Marrow Cells cytology, Bone Marrow Cells drug effects, Bone Marrow Cells metabolism, Cell Proliferation drug effects, Chromatin Immunoprecipitation, Dual Specificity Phosphatase 1 metabolism, Electrophoretic Mobility Shift Assay, Gene Expression drug effects, JNK Mitogen-Activated Protein Kinases genetics, JNK Mitogen-Activated Protein Kinases metabolism, Kinetics, Macrophage Activation drug effects, Macrophages cytology, Macrophages metabolism, Mice, Mice, Inbred BALB C, Protein Binding, Proto-Oncogene Proteins c-jun genetics, Proto-Oncogene Proteins c-jun metabolism, Proto-Oncogene Proteins c-raf genetics, Proto-Oncogene Proteins c-raf metabolism, RNA, Small Interfering genetics, Reverse Transcriptase Polymerase Chain Reaction, Transfection, Cyclic AMP Response Element-Binding Protein metabolism, Dual Specificity Phosphatase 1 genetics, Lipopolysaccharides pharmacology, Macrophage Colony-Stimulating Factor pharmacology, Macrophages drug effects, Transcription Factor AP-1 metabolism
- Abstract
MAPK phosphatase-1 (MKP-1) is a protein phosphatase that plays a crucial role in innate immunity. This phosphatase inactivates ERK1/2, which are involved in two opposite functional activities of the macrophage, namely proliferation and activation. Here we found that although macrophage proliferation and activation induce MKP-1 with different kinetics, gene expression is mediated by the proximal promoter sequences localized between -380 and -180 bp. Mutagenesis experiments of the proximal element determined that CRE/AP-1 is required for LPS- or M-CSF-induced activation of the MKP-1 gene. Moreover, the results from gel shift analysis and chromatin immunoprecipitation indicated that c-Jun and CREB bind to the CRE/AP-1 box. The distinct kinetics shown by M-CSF and LPS correlates with the induction of JNK and c-jun, as well as the requirement for Raf-1. The signal transduction pathways that activate the induction of MKP-1 correlate kinetically with induction by M-CSF and LPS.
- Published
- 2009
- Full Text
- View/download PDF
24. Homogeneous conjugation of peptides onto gold nanoparticles enhances macrophage response.
- Author
-
Bastús NG, Sánchez-Tilló E, Pujals S, Farrera C, López C, Giralt E, Celada A, Lloberas J, and Puntes V
- Subjects
- Cytokines metabolism, Macrophages metabolism, Gold chemistry, Macrophages cytology, Metal Nanoparticles, Peptides chemistry
- Abstract
Murine bone marrow macrophages were able to recognize gold nanoparticle peptide conjugates, while peptides or nanoparticles alone were not recognized. Consequently, in the presence of conjugates, macrophage proliferation was stopped and pro-inflammatory cytokines such as TNF-alpha, IL-1beta, and IL-6, as well as nitric oxide synthase (NOS2) were induced. Furthermore, macrophage activation by gold nanoparticles conjugated to different peptides appeared to be rather independent of peptide length and polarity, but dependent on peptide pattern at the nanoparticle surface. Correspondingly, the biochemical type of response also depended on the type of conjugated peptide and could be correlated with the degree of ordering in the peptide coating. These findings help to illustrate the basic requirements involved in medical nanoparticle conjugate design to either activate the immune system or hide from it in order to reach their targets before being removed by phagocytes.
- Published
- 2009
- Full Text
- View/download PDF
25. Peptides conjugated to gold nanoparticles induce macrophage activation.
- Author
-
Bastús NG, Sánchez-Tilló E, Pujals S, Farrera C, Kogan MJ, Giralt E, Celada A, Lloberas J, and Puntes V
- Subjects
- Adjuvants, Immunologic, Animals, Cell Proliferation drug effects, Gold metabolism, Macrophages immunology, Mice, Mice, Inbred BALB C, Mice, Inbred C3H, Microscopy, Electron, Transmission, Peptides metabolism, Toll-Like Receptor 4 immunology, Toll-Like Receptor 4 metabolism, Gold pharmacology, Macrophage Activation, Macrophages drug effects, Metal Nanoparticles, Peptides pharmacology
- Abstract
Macrophages that react against pathogenic organisms can also be activated with artificial nanometric units consisting of gold nanoparticles (Au NPs) with a peptide coating. Using bone marrow-derived macrophages, here we show that these cells have the capacity to recognize Au NPs once conjugated to two biomedically relevant peptides, the amyloid growth inhibitory peptide (AGIP) and the sweet arrow peptide (SAP), while they do not recognize peptides or NPs alone. The recognition of these conjugates by macrophages is mediated by a pattern recognition receptor, the TLR-4. Consequently, pro-inflammatory cytokines such as TNF-alpha, IL-1 beta and IL-6, as well as nitric oxide synthase were induced and macrophage proliferation was stopped when exposed to the peptide-conjugated Au NPs. Contamination by lipopolysaccharide in our experimental system was excluded. Furthermore, macrophage activation appeared to be independent of peptide length and polarity. As a result of macrophage activation, conjugated Au NPs were internalized and processed. These results open up a new avenue in the world of adjuvants and illustrate the basic requirements for the design of NP conjugates that efficiently reach their target.
- Published
- 2009
- Full Text
- View/download PDF
26. IFN-{gamma}-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation.
- Author
-
Valledor AF, Arpa L, Sánchez-Tilló E, Comalada M, Casals C, Xaus J, Caelles C, Lloberas J, and Celada A
- Subjects
- Animals, Bone Marrow Cells cytology, Cell Cycle Proteins, Cell Proliferation, Macrophage Activation, Macrophage Colony-Stimulating Factor metabolism, Macrophages metabolism, Mice, Mice, Inbred BALB C, Phenotype, Signal Transduction, Dual Specificity Phosphatase 1 biosynthesis, Gene Expression Regulation, Enzymologic, Interferon-gamma metabolism, MAP Kinase Signaling System, Macrophages enzymology
- Abstract
Macrophages have the capacity to proliferate in response to specific growth factors, such as macrophage-colony stimulating factor (M-CSF). In the presence of several cytokines and activating factors, macrophages undergo growth arrest, become activated, and participate in the development of an immune response. We have previously observed that activation of extracellularly regulated kinase 1/2 (ERK-1/2) is required for macrophage proliferation in response to growth factors. A short and early pattern of ERK activity correlated with the proliferative response. In contrast, slightly prolonged patterns of activity of these kinases were induced by signals that lead to macrophage activation and growth arrest. IFN-gamma is the main endogenous Th1-type macrophage activator. Here we report that stimulation with IFN-gamma prolongs the pattern of ERK activity induced by M-CSF in macrophages. These effects correlate with IFN-gamma-mediated inhibition of the expression of several members of the MAPK phosphatase family, namely MKP-1, -2, and -4. Moreover, inhibition of MKP-1 expression using siRNA technology or synthetic inhibitors also led to elongated ERK activity and significant blockage of M-CSF-dependent proliferation. These data suggest that subtle changes in the time course of activity of members of the MAPK family contribute to the antiproliferative effects of IFN-gamma in macrophages.
- Published
- 2008
- Full Text
- View/download PDF
27. Selective roles of MAPKs during the macrophage response to IFN-gamma.
- Author
-
Valledor AF, Sánchez-Tilló E, Arpa L, Park JM, Caelles C, Lloberas J, and Celada A
- Subjects
- Animals, Cells, Cultured, Gene Expression Regulation, Enzymologic drug effects, Mice, Mice, Inbred BALB C, Mitogen-Activated Protein Kinases antagonists & inhibitors, Mitogen-Activated Protein Kinases genetics, Phosphoserine metabolism, Protein Kinase Inhibitors pharmacology, RNA Stability drug effects, STAT1 Transcription Factor metabolism, Interferon-gamma pharmacology, Macrophages drug effects, Macrophages enzymology, Mitogen-Activated Protein Kinases metabolism
- Abstract
Macrophages perform essential functions in the infection and resolution of inflammation. IFN-gamma is the main endogenous macrophage Th1 type activator. The classical IFN-gamma signaling pathway involves activation of Stat-1. However, IFN-gamma has also the capability to activate members of the MAPK family. In primary bone marrow-derived macrophages, we have observed strong activation of p38 at early time points of IFN-gamma stimulation, whereas weak activation of ERK-1/2 and JNK-1 was detected at a more delayed stage. In parallel, IFN-gamma exerted repressive effects on the expression of a number of MAPK phosphatases. By using selective inhibitors and knockout models, we have explored the contributions of MAPK activation to the macrophage response to IFN-gamma. Our findings indicate that these kinases regulate IFN-gamma-mediated gene expression in a rather selective way: p38 participates mainly in the regulation of the expression of genes required for the innate immune response, including chemokines such as CCL5, CXCL9, and CXCL10; cytokines such as TNF-alpha; and inducible NO synthase, whereas JNK-1 acts on genes involved in Ag presentation, including CIITA and genes encoding MHC class II molecules. Modest effects were observed for ERK-1/2 in these studies. Interestingly, some of the MAPK-dependent changes in gene expression observed in these studies are based on posttranscriptional regulation of mRNA stability.
- Published
- 2008
- Full Text
- View/download PDF
28. JNK1 Is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharide-dependent activation.
- Author
-
Sánchez-Tilló E, Comalada M, Xaus J, Farrera C, Valledor AF, Caelles C, Lloberas J, and Celada A
- Subjects
- Animals, Cells, Cultured, Cytokines biosynthesis, Dual Specificity Phosphatase 1, MAP Kinase Signaling System drug effects, Macrophage Activation drug effects, Macrophage Colony-Stimulating Factor pharmacology, Macrophages cytology, Mice, Mice, Inbred BALB C, Mice, Knockout, Nitric Oxide metabolism, Phosphoprotein Phosphatases deficiency, Protein Phosphatase 1, Cell Cycle Proteins biosynthesis, Immediate-Early Proteins biosynthesis, Lipopolysaccharides pharmacology, MAP Kinase Signaling System physiology, Macrophage Activation physiology, Macrophages enzymology, Mitogen-Activated Protein Kinase 8 metabolism, Phosphoprotein Phosphatases biosynthesis, Protein Tyrosine Phosphatases biosynthesis
- Abstract
Macrophages proliferate in the presence of their growth factor, macrophage colony-stimulating factor (M-CSF), in a process that is dependent on early and short ERK activation. Lipopolysaccharide (LPS) induces macrophage activation, stops proliferation, and delays ERK phosphorylation, thereby triggering an inflammatory response. Proliferating or activating responses are balanced by the kinetics of ERK phosphorylation, the inactivation of which correlates with Mkp1 induction. Here we show that the transcriptional induction of this phosphatase by M-CSF or LPS depends on JNK but not on the other MAPKs, ERK and p38. The lack of Mkp1 induction caused by JNK inhibition prolonged ERK-1/2 and p38 phosphorylation. The two JNK genes, jnk1 and jnk2, are constitutively expressed in macrophages. However, only the JNK1 isoform was phosphorylated and, as determined in single knock-out mice, was necessary for Mkp1 induction by M-CSF or LPS. JNK1 was also required for pro-inflammatory cytokine biosynthesis (tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6) and LPS-induced NO production. This requirement is independent of Mkp1 expression, as shown in Mkp1 knock-out mice. Our results demonstrate a critical role for JNK1 in the regulation of Mkp1 induction and in LPS-dependent macrophage activation.
- Published
- 2007
- Full Text
- View/download PDF
29. NMR structural studies of the ItchWW3 domain reveal that phosphorylation at T30 inhibits the interaction with PPxY-containing ligands.
- Author
-
Morales B, Ramirez-Espain X, Shaw AZ, Martin-Malpartida P, Yraola F, Sánchez-Tilló E, Farrera C, Celada A, Royo M, and Macias MJ
- Subjects
- Animals, Ligands, Mice, Phosphorylation, Protein Structure, Tertiary, Magnetic Resonance Spectroscopy, Ubiquitin-Protein Ligases chemistry, Ubiquitin-Protein Ligases metabolism, Viral Matrix Proteins metabolism
- Abstract
In this work, we study the role of phosphorylation as a regulatory mechanism for the interaction between the E3 ubiquitin ligase ItchWW3 domain and two PPxY motifs of one of its targets, the Epstein-Barr virus latent membrane protein 2A. Whereas ligand phosphorylation only diminishes binding, domain phosphorylation at residue T30 abrogates it. We show that two ItchWW domains can be phosphorylated at this position, using CK2 and PKA kinases and/or with stimulated T lymphocyte lysates. To better understand the regulation process, we determined the NMR structures of the ItchWW3-PPxY complex and of the phosphoT30-ItchWW3 variant. The peptide binds the domain using both XP and tyrosine grooves. A hydrogen bond from T30 to the ligand is also detected. This hydrogen-bond formation is precluded in the variant, explaining the inhibition upon phosphorylation. Our results suggest that phosphorylation at position 30 in ItchWW domains can be a mechanism to inhibit target recognition in vivo.
- Published
- 2007
- Full Text
- View/download PDF
30. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
- Author
-
Villalonga N, Escalada A, Vicente R, Sánchez-Tilló E, Celada A, Solsona C, and Felipe A
- Subjects
- Animals, Biophysical Phenomena, Biophysics, Cells, Cultured, Mice, Scorpion Venoms pharmacology, Kv1.3 Potassium Channel metabolism, Kv1.5 Potassium Channel metabolism, Macrophages drug effects, Macrophages metabolism
- Abstract
Voltage-dependent K(+) (Kv) channels are involved in the immune response. Kv1.3 is highly expressed in activated macrophages and T-effector memory cells of autoimmune disease patients. Macrophages are actively involved in T-cell activation by cytokine production and antigen presentation. However, unlike T-cells, macrophages express Kv1.5, which is resistant to Kv1.3-drugs. We demonstrate that mononuclear phagocytes express different Kv1.3/Kv1.5 ratios, leading to biophysically and pharmacologically distinct channels. Therefore, Kv1.3-based treatments to alter physiological responses, such as proliferation and activation, are impaired by Kv1.5 expression. The presence of Kv1.5 in the macrophagic lineage should be taken into account when designing Kv1.3-based therapies.
- Published
- 2007
- Full Text
- View/download PDF
31. Macrophage-colony-stimulating factor-induced proliferation and lipopolysaccharide-dependent activation of macrophages requires Raf-1 phosphorylation to induce mitogen kinase phosphatase-1 expression.
- Author
-
Sánchez-Tilló E, Comalada M, Farrera C, Valledor AF, Lloberas J, and Celada A
- Subjects
- Animals, Cell Cycle immunology, Cell Cycle Proteins metabolism, Cells, Cultured, Cytokines biosynthesis, Dual Specificity Phosphatase 1, Enzyme Induction immunology, Extracellular Signal-Regulated MAP Kinases metabolism, Immediate-Early Proteins metabolism, Macrophages cytology, Macrophages enzymology, Macrophages immunology, Mice, Mice, Inbred BALB C, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism, Phosphoprotein Phosphatases metabolism, Phosphorylation, Protein Kinase C-epsilon metabolism, Protein Phosphatase 1, Protein Tyrosine Phosphatases metabolism, Proto-Oncogene Proteins c-raf antagonists & inhibitors, Cell Cycle Proteins biosynthesis, Cell Proliferation, Immediate-Early Proteins biosynthesis, Lipopolysaccharides pharmacology, Macrophage Activation immunology, Macrophage Colony-Stimulating Factor physiology, Phosphoprotein Phosphatases biosynthesis, Protein Tyrosine Phosphatases biosynthesis, Proto-Oncogene Proteins c-raf metabolism
- Abstract
Macrophages are key regulators of immune responses. In the absence of an activating signal, murine bone marrow-derived macrophages undergo proliferation in response to their specific growth factor, namely M-CSF. The addition of bacterial LPS results in macrophage growth arrest and their engagement in a proinflammatory response. Although participation of ERKs is required for both macrophage proliferation and activation, ERK phosphorylation follows a more delayed pattern in response to activating agents. In primary macrophages, mitogen kinase phosphatase-1 (MKP-1) is a key regulator of the time course of MAPK activity. Here we showed that MKP-1 expression is dependent on Raf-1 activation. The time course of Raf-1 activation correlated with that of ERK-1/2. However, whereas ERK phosphorylation in response to M-CSF is Raf-1 dependent, in response to LPS, an alternative pathway directs the activation of these kinases. Inhibition of Raf-1 activity increased the expression of cyclin-dependent kinase inhibitors and growth arrest. In contrast, no effect was observed in the expression of proinflammatory cytokines and inducible NO synthase following LPS stimulation. The data reported here reveal new insights into how signaling determines opposing macrophage functions.
- Published
- 2006
- Full Text
- View/download PDF
32. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages.
- Author
-
Vicente R, Escalada A, Coma M, Fuster G, Sánchez-Tilló E, López-Iglesias C, Soler C, Solsona C, Celada A, and Felipe A
- Subjects
- Animals, Bone Marrow Cells, Cell Division, Cells, Cultured, Gene Expression Regulation, Kv1.3 Potassium Channel, Lipopolysaccharides pharmacology, Macrophage Colony-Stimulating Factor pharmacology, Macrophages cytology, Mice, Mice, Knockout, Patch-Clamp Techniques, Potassium Channels biosynthesis, Potassium Channels, Inwardly Rectifying biosynthesis, Potassium Channels, Voltage-Gated metabolism, Tumor Necrosis Factor-alpha physiology, Macrophage Activation, Macrophages physiology, Potassium Channels, Voltage-Gated biosynthesis
- Abstract
Voltage-dependent K+ channels (VDPC) are expressed in most mammalian cells and involved in the proliferation and activation of lymphocytes. However, the role of VDPC in macrophage responses is not well established. This study was undertaken to characterize VDPC in macrophages and determine their physiological role during proliferation and activation. Macrophages proliferate until an endotoxic shock halts cell growth and they become activated. By inducing a schedule that is similar to the physiological pattern, we have identified the VDPC in non-transformed bone marrow-derived macrophages and studied their regulation. Patch clamp studies demonstrated that cells expressed outward delayed and inwardly rectifying K+ currents. Pharmacological data, mRNA, and protein analysis suggest that these currents were mainly mediated by Kv1.3 and Kir2.1 channels. Macrophage colony-stimulating factor-dependent proliferation induced both channels. Lipopolysaccharide (LPS)-induced activation differentially regulated VDPC expression. While Kv1.3 was further induced, Kir2.1 was down-regulated. TNF-alpha mimicked LPS effects, and studies with TNF-alpha receptor I/II double knockout mice demonstrated that LPS regulation mediates such expression by TNF-alpha-dependent and -independent mechanisms. This modulation was dependent on mRNA and protein synthesis. In addition, bone marrow-derived macrophages expressed Kv1.5 mRNA with no apparent regulation. VDPC activities seem to play a critical role during proliferation and activation because not only cell growth, but also inducible nitric-oxide synthase expression were inhibited by blocking their activities. Taken together, our results demonstrate that the differential regulation of VDPC is crucial in intracellular signals determining the specific macrophage response.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.